09:45 AM EST - IMRIS Inc. : announced that the Company's InSituTM wireless coil and Monteris NeuroBlate® laser ablation system have been used together for the first time at a leading United States neuroscience centre. This combination brought improved visualization and workflow in removing a patient's low-grade glioma brain tumor inside a VISIUS® Surgical Theatre. IMRIS Inc.
shares T.IM are trading unchanged at $0.85.
